Amantadine Therapy for Cognitive Impairment in Long COVID

Clinical trial NCT06055244 · COMPLETED

Trial details

NCT number: NCT06055244
Sponsor: Ohio State University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Long COVID Post-COVID19 Condition Post-Acute COVID19 Syndrome

Start date: 2023-12-07
Primary completion: 2025-12-11
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.